Title: Daniel Ivansson - Innovator in Nucleic Acid Technologies
Introduction
Daniel Ivansson is an inventor based in Uppsala, Sweden. He is currently associated with Olink Bioscience AB, where he focuses on advancements in nucleic acid technologies. Despite having no granted patents to his name, his contributions to the field are noteworthy.
Latest Patent Applications
Daniel Ivansson has been involved in several significant patent applications. One of his latest applications is titled "Methods for the Selection of Nucleic Acid Sequences." This disclosure relates to a method for targeted integration of a donor vector into a specific pre-defined genomic location of an isolated eukaryotic host cell. The vector and host cell together comprise nucleic acid components allowing for the selection of cells having integrated the donor vector into the pre-defined genomic location of the host cell. More specifically, the present method provides for the selection of sequence optimized nucleic acid sequence variants. Such optimized nucleic acid sequence variants may comprise sequence optimized expression vector components for subsequent use in recombinant protein production.
Another notable application is "Fc Binding Polypeptides." This disclosure relates to a class of engineered polypeptides having a binding affinity for the Fc region of immunoglobulins while exhibiting a significantly reduced binding affinity to the VH3 region of immunoglobulins. The present disclosure also relates to methods for isolating an immunoglobulin using said polypeptides as well as to related products, such as separation matrices.
Conclusion
Daniel Ivansson is making strides in the field of nucleic acid technologies through his innovative patent applications. His work at Olink Bioscience AB highlights his commitment to advancing scientific research and development.